OBJECTIVES: To determine the effect of heart donors with @entity854 on short and long-term outcomes on heart transplant recipients. METHODS: Retrospective chart review of heart donors used over 6 y. Donor charts provided demographic information, cause of @entity204 , and echo results. Recipient charts were queried for predischarge echo and survival results. RESULTS: From January 1999 to December 2005, 485 heart transplants were performed. Of these, 50 donors had 70 echo abnormalities. Mean donor age was 32 y (range 4-51 y). Echo abnormalities included wall motion abnormality in 30 (60%), @entity4346 in 20 (40%), @entity339 in 16 (32%), @entity337 in 2 (4%), and left ventricle dilation in 2 (4%). Mean ejection fraction was 54.0% (range 40%-70%). Echo abnormalities post-transplant decreased significantly to 18 (64% decrease) @entity1 with 21 (70% decrease) echo abnormalities. @entity854 resolved in 27 (90% decrease) @entity1 (P < 0.01), @entity4346 resolved in 14 (70% decrease) @entity1 (P < 0.01), and @entity339 resolved in 12 (75% decrease) @entity1 (P < 0.01). @entity337 and left ventricle dilation resolved in 2 @entity1 . However, right ventricle dilation significantly increased in 8 @entity1 (P < 0.01). Mean ejection fraction at discharge was 56.9% (range 45%-89%). Overall survival was 96% at a mean follow-up of 4 y (range 2-6 y). CONCLUSION: Majority of @entity854 in donor hearts resolve prior to discharge and 4 y survival rates are excellent.

Survival is not compromised in donor hearts with XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity339 :: ('MESH:D008944', 'Disease') :: ['mitral regurgitation'] @entity854 :: ('MESH:D018376', 'Disease') :: ['Wall motion abnormalities', 'echocardiographic abnormalities'] @entity4346 :: ('MESH:D017379', 'Disease') :: ['left ventricular hypertrophy'] @entity337 :: ('MESH:D001022', 'Disease') :: ['Aortic regurgitation', 'aortic regurgitation'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity854 :: (MESH:D018376,Disease) :: ['echocardiographic abnormalities']
